Premium
Avanafil (Spedra): increasing the choice of PDE‐5 inhibitors
Author(s) -
Chaplin Steve
Publication year - 2014
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1229
Subject(s) - medicine , traditional medicine
Avanafil is a new PDE‐5 inhibitor for treating erectile dysfunction. In our New products review, Steve Chaplin presents the data relating to its efficacy and adverse effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom